> Detailanzeige

Platek, Mary E.; McCloskey, Susan A.; Cruz, Myra; Burke, Mark S.; Reid, Mary E.; Wilding, Gregory E.; Rigual, Nestor R.; Popat, Saurin R.; Loree, Thom R.; Gupta, Vishal; Warren, Graham W.; Sullivan, Maureen; Hicks, Wesley L.; Singh, Anurag K.

Quantification of the effect of treatment duration on local‐regional failure after definitive concurrent chemotherapy and intensity‐modulated radiation therapy for squamous cell carcinoma of the head and neck

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Quantification of the effect of treatment duration on local‐regional failure after definitive concurrent chemotherapy and intensity‐modulated radiation therapy for squamous cell carcinoma of the head and neck
  • Beteiligte: Platek, Mary E.; McCloskey, Susan A.; Cruz, Myra; Burke, Mark S.; Reid, Mary E.; Wilding, Gregory E.; Rigual, Nestor R.; Popat, Saurin R.; Loree, Thom R.; Gupta, Vishal; Warren, Graham W.; Sullivan, Maureen; Hicks, Wesley L.; Singh, Anurag K.
  • Erschienen: Wiley, 2013
  • Erschienen in: Head & Neck
  • Sprache: Englisch
  • DOI: 10.1002/hed.23024
  • ISSN: 1043-3074; 1097-0347
  • Schlagwörter: Otorhinolaryngology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The purpose of this study was to quantify the effect of treatment duration on locoregional progression after definitive concurrent chemoradiation (CCRT) for squamous cell carcinoma of the head and neck (SCCHN).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We conducted a retrospective chart review of patients treated between 2004 and 2010. After a prior analysis, measures were taken to limit therapy beyond 7 weeks. Comparison of outcomes were made between cohorts 1 (2004–2007, <jats:italic>n</jats:italic> = 78) and 2 (2007–2010, <jats:italic>n</jats:italic> = 62).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Median therapy duration was statistically significantly different between cohorts as follows: 51 days, cohort 1 and 46 days, cohort 2 (<jats:italic>p</jats:italic> &lt; .01). Locoregional progression in cohorts 1 and 2 was 19% and 5% (<jats:italic>p</jats:italic> = .01), respectively. On multivariate analysis, patients with prolonged treatment (≥57 days) had an 8‐fold increase in risk of locoregional progression compared to patients who completed on time (<jats:italic>p</jats:italic> &lt; .01).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Treatment duration was a significant predictor of locoregional progression in patients with SCCHN who received definitive CCRT. © 2012 Wiley Periodicals, Inc. Head Neck, 2013</jats:p></jats:sec>